Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban

Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban

Stroke patients can recover upon intravenous thrombolysis but remain impaired in lacking recanalization. We sought to investigate the clinical effect of systemic thrombolysis with an intravenous bolus of 20 mg recombinant tissue plasminogen activator (rtPA) and an infusion of body-weight adjusted ti...

Full description

Bibliographic Details
Main Authors:	Rudiger J. Seitz, Judith Sukiennik, Mario Siebler
Format:	Article
Language:	English
Published:	MDPI AG 2012-09-01
Series:	Neurology International
Subjects:	brain infarct, stroke, thrombolysis, tirofiban, impairment
Online Access:	http://www.pagepress.org/journals/index.php/ni/article/view/3665

Similar Items

Efficacy and safety of tirofiban in patients with acute ischemic stroke without large-vessel occlusion and not receiving intravenous thrombolysis: A randomized controlled open-label trial
by: Yongpeng Yu, et al.
Published: (2022-12-01)

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
by: Yunzhu Liu, et al.
Published: (2022-11-01)

Safety and Efficacy of Tirofiban During Intravenous Thrombolysis Bridging to Mechanical Thrombectomy for Acute Ischemic Stroke Patients: A Meta-Analysis
by: Wei Li, et al.
Published: (2022-04-01)

Adjuvant Tirofiban Injection Through Deployed Solitaire Stent As a Rescue Technique After failed Mechanical Thrombectomy in Acute Stroke
by: Jung Hwa Seo, et al.
Published: (2015-02-01)

Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis
by: Yan Zhang, et al.
Published: (2022-10-01)

EFFICACY OF INTRAVENOUS TIROFIBAN THERAPY IN LACUNAR STROKE PATIENTS
by: Ahmet Yabalak, et al.
Published: (2023-06-01)

SAFETY OF TIROFIBAN FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN ROUTINE CLINICAL PRACTICE
by: Yan-Jun Zhang, et al.
Published: (2014-04-01)

Safety and Efficacy of Low-Dose Tirofiban Combined With Intravenous Thrombolysis and Mechanical Thrombectomy in Acute Ischemic Stroke: A Matched-Control Analysis From a Nationwide Registry
by: Gaoting Ma, et al.
Published: (2021-06-01)

Intra-arterial tirofiban in a male nonagenarian with acute ischemic stroke: A case report
by: Ding Xianhui, et al.
Published: (2019-12-01)

Safety and efficacy of low-dose and long-course tirofiban in large hemispheric infarction
by: Yinqin Hu, et al.
Published: (2022-09-01)

Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke
by: Chunrong Tao, et al.
Published: (2021-06-01)

Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke Etiology
by: Chao Sun, et al.
Published: (2019-10-01)

Safety and Efficacy of Tirofiban in Severe Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
by: Lingxin Cai, et al.
Published: (2022-11-01)

Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
by: Yang Zhang, et al.

Association of tirofiban treatment with outcomes following endovascular therapy in cardioembolic stroke: insights from the RESCUE BT randomized trial
by: Benbing Rong, et al.
Published: (2023-11-01)

Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
by: Yun Ho Noh, et al.
Published: (2022-03-01)

Hemorragia alveolar asociada con tirofiban
by: Alexander Aguilar Arias, et al.
Published: (2023-03-01)

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
by: Baumann Gert, et al.
Published: (2005-05-01)

High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study
by: Mohammed A Balghith
Published: (2012-01-01)

Thrombolysis Outcomes in Acute Ischaemic Stroke Patients with Pre-Existing Cognitive Impairment
by: Isabela V. P. Ramnarine, et al.
Published: (2023-04-01)

The efficacy and safety of continuous intravenous tirofiban for acute ischemic stroke patients treated by endovascular therapy: a meta-analysis
by: Mengmeng Wang, et al.
Published: (2024-04-01)

Can Tirofiban Improve the Outcome of Patients With Acute Ischemic Stroke: A Propensity Score Matching Analysis
by: Lingxin Cai, et al.
Published: (2021-09-01)

Tirofiban induced diffuse alveolar hemorrhage
by: Deepak Kadeli, et al.
Published: (2018-05-01)

Safety Profile of Intra-Arterial Tirofiban as a Rescue Therapy during Mechanical Thrombectomy in Acute Ischemic Stroke
by: Karthikeyan Muthugounder Athiyappan, et al.
Published: (2024-04-01)

Treatment of intravenous thrombolysis with half-dose recombinant human prourokinase reduces the rate of tirofiban use during early routine catheterization period
by: Chao Jiang, et al.
Published: (2022-07-01)

Mechanical Solitaire Thrombectomy with Low-Dose Booster Tirofiban Injection
by: Duck-Ho Goh, et al.
Published: (2016-09-01)

Adjunct Intraarterial or Intravenous Tirofiban Versus No Tirofiban After Successful Recanalization of Basilar Artery Occlusion Stroke: The BASILAR Registry
by: Huagang Li, et al.
Published: (2024-03-01)

Intravenous thrombolysis in acute ischemic stroke
by: Tudor Cuciureanu, et al.
Published: (2017-06-01)

Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion
by: Xiding Pan, et al.
Published: (2022-12-01)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
by: Dong Huang, et al.
Published: (2021-08-01)

Case report: reuse of tirofiban leads to very severe thrombocytopenia
by: Yuqing Li, et al.
Published: (2023-05-01)

Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow‐up
by: Li Deng, et al.
Published: (2021-11-01)

Intravenous thrombolysis in acute ischemic stroke
by: M. A. Domashenko, et al.
Published: (2017-02-01)

Feasibility of switching from alteplase to tenecteplase for stroke thrombolysis – A retrospective cohort analysis
by: Vilhelm Sjögren, et al.
Published: (2023-06-01)

Low-dose intravenous tirofiban infusion after endovascular recanalization for non-acute middle cerebral artery occlusion
by: Zhang Xi, et al.
Published: (2022-12-01)

Predictors of intracerebral hemorrhage in acute stroke patients receiving intravenous recombinant tissue plasminogen activator
by: Vijay Chenna, et al.
Published: (2018-01-01)

Safety and Efficacy of Tirofiban for Acute Ischemic Stroke Patients With Large Artery Atherosclerosis Stroke Etiology Undergoing Endovascular Therapy
by: Xiaochuan Huo, et al.
Published: (2021-02-01)

Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke
by: Bin Han, et al.
Published: (2022-02-01)

Stroke thrombolysis or not for an intraventricular thrombus
by: Josef Finsterer, et al.
Published: (2023-03-01)

EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
by: T. V. Demin, et al.
Published: (2010-03-01)